Physician

David Wilkin Parke, MD

According to 2025 Medicare claims, David Parke, MD (NPI: 1265638746) practices ophthalmology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is VITREO RETINAL SURGERY PLLC (NPI: 1891783965; TIN: 411608615) and primary practice location at 56303-2253.

Parke's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,282 traditional Medicare patients, billed 43,801 HCPCS/CPT codes, and received $4,974,855 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,074 prescription claims across 358 beneficiaries totaling $38,717 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 166 records totaling $487,333. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,415,805 to $4,974,855. Similarly, Part D prescription costs have risen steadily, from $33,057 to $38,717. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.5M$5.0M2015 Medicare payment: $1,415,805 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,751,217 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,148,139 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,924,306 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,353,121 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,590,080 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,965,064 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,701,323 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,849,390 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,974,855 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157528,635$1,415,805
201684610,683$1,751,217
201797813,553$2,148,139
20181,10116,001$2,924,306
20191,51422,918$4,353,121
20201,34820,526$4,590,080
20211,33919,721$4,965,064
20221,32420,914$4,701,323
20231,33548,265$4,849,390
20241,28243,801$4,974,855

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$28K$55K2015 Drug cost: $33,057 (USD; Tot_Drug_Cst)2016 Drug cost: $24,885 (USD; Tot_Drug_Cst)2017 Drug cost: $32,605 (USD; Tot_Drug_Cst)2018 Drug cost: $43,664 (USD; Tot_Drug_Cst)2019 Drug cost: $45,244 (USD; Tot_Drug_Cst)2020 Drug cost: $36,846 (USD; Tot_Drug_Cst)2021 Drug cost: $47,821 (USD; Tot_Drug_Cst)2022 Drug cost: $55,019 (USD; Tot_Drug_Cst)2023 Drug cost: $47,380 (USD; Tot_Drug_Cst)2024 Drug cost: $38,717 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015247825$33,057
2016241726$24,885
2017277864$32,605
20183331,143$43,664
2019288969$45,244
2020268915$36,846
20212901,083$47,821
20223121,103$55,019
20233261,092$47,380
20243581,074$38,717

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3523,158$656
67028Injection of drug into eye6762,585$100
92014Established patient complete exam of visual system550632$87
92012Established patient problem focused exam of visual system464677$67
92134Imaging of retina1,2603,481$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate22310,283$13,608
Ketorolac TromethamineKetorolac Tromethamine24811,578$4,949
Brimonidine TartrateBrimonidine Tartrate562,998$1,787
DifluprednateDifluprednate15275$1,679
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat816,164$1,614

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.166$487,333Apellis Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Wilkin Parke, MD?

Tedicare shows public-source Medicare data for David Wilkin Parke, MD (NPI 1265638746), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Wilkin Parke, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Wilkin Parke, MD?

David Wilkin Parke, MD is linked to VITREO RETINAL SURGERY PLLC (billing NPI 1891783965) in the available physician profile data.

Does David Wilkin Parke, MD have Open Payments data?

David Wilkin Parke, MD has 166 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.